In this study, we observed that MGCD-265, a small molecule inhibitor targeting Recepteur d’Origine Nantais (MST1R, RON), exhibited a low IC50 value for gallbladder cancer cell lines. This evidence concerns the gene MST1R and gallbladder cancer.